Quarterly report pursuant to Section 13 or 15(d)

Note 13 - Segment Reporting - Segment Reporting Financial Information (Details)

v3.8.0.1
Note 13 - Segment Reporting - Segment Reporting Financial Information (Details) - USD ($)
 3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Revenues $ 7,098,000 $ 5,507,000
Operating income (loss) (439,065) (1,705,311)
Depreciation and amortization 387,417 577,987
Operating income (loss) (439,065) (1,705,311)
Other (expense) income, net (11,194) (19,465)
Loss before income tax expense (450,259) (1,724,776)
Operating Segments [Member]    
Operating income (loss) 1,926,000 216,000
Operating income (loss) 1,926,000 216,000
Corporate, Non-Segment [Member]    
Operating income (loss) (2,365,000) (1,921,000)
Operating income (loss) (2,365,000) (1,921,000)
Corporate Clinics [Member]    
Revenues 3,257,000 2,497,000
Operating income (loss) 111,000 (1,017,000)
Depreciation and amortization 303,000 444,000
Operating income (loss) 111,000 (1,017,000)
Franchise Operations [Member]    
Revenues 3,841,000 3,010,000
Operating income (loss) 1,815,000 1,233,000
Depreciation and amortization
Operating income (loss) 1,815,000 1,233,000
Corporate Segment [Member]    
Depreciation and amortization $ 84,000 $ 134,000